Effect of Homoeopathic medicines in Rheumatoid Arthritis

An Open Label Non Randomized Clinical Trial to Evaluate the Efficacy of Homoeopathic medicine in reducing the Anti Cyclic Citrullinated Peptide Levels in Rheumatoid Arthritis

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/021895

Enrollment

Registered

2019-11-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M05- Rheumatoid arthritis with rheumatoid factor

Interventions

Intervention1: Homoeopathic Medicines: Individualised Homoeopathic medicines in which dose and frequency will be according to Homoeopathic Principles. oral route of administration duration of therap

Eligibility

Inclusion criteria

Inclusion criteria: Cases with Anti CCP above 20 IU/ml Cases fulfilling the diagnostic criteria of rheumatoid arthritis

Exclusion criteria

Exclusion criteria: Patients with any known serious co-morbities of Rheumatoid Arthritis Patients on NSAIDs/DMARDs Rheumatoid Arthritis associated with complicated systemic disease Pregnant women and lactating mothers Immuno compromised patients

Design outcomes

Primary

Measure	Time frame
symptomatic improvement in RA patients with reduction in anti CCP and RA values.Timepoint: 1 year followup	—

Secondary

Measure	Time frame
symptomatic improvement in patients using the RASS (Rheumatoid Arthritis Severity Scale)Timepoint: 1 year followup	—

Countries

India

Contacts

Public ContactHafsa Muhammed

National Homoeopathy Research Institute in Mental Health

sitharthan.r@gmail.com9443203174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026